Neurogene Statistics Share Statistics Neurogene has 14.26M
shares outstanding. The number of shares has increased by 9.76%
in one year.
Shares Outstanding 14.26M Shares Change (YoY) 9.76% Shares Change (QoQ) -4.47% Owned by Institutions (%) 71.83% Shares Floating 11.75M Failed to Deliver (FTD) Shares 201 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 2.55M, so 17.9% of the outstanding
shares have been sold short.
Short Interest 2.55M Short % of Shares Out 17.9% Short % of Float 22.72% Short Ratio (days to cover) 9.27
Valuation Ratios The PE ratio is -5.34 and the forward
PE ratio is -4.04.
Neurogene's PEG ratio is
-0.09.
PE Ratio -5.34 Forward PE -4.04 PS Ratio 434.14 Forward PS 627.8 PB Ratio 1.29 P/FCF Ratio -5.62 PEG Ratio -0.09
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Neurogene.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.84,
with a Debt / Equity ratio of 0.04.
Current Ratio 20.84 Quick Ratio 20.84 Debt / Equity 0.04 Debt / EBITDA -0.17 Debt / FCF -0.17 Interest Coverage -6883.75
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $8.64K Profits Per Employee $-702.28K Employee Count 107 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -41.31% in the
last 52 weeks. The beta is 1.7, so Neurogene's
price volatility has been higher than the market average.
Beta 1.7 52-Week Price Change -41.31% 50-Day Moving Average 20.35 200-Day Moving Average 21.59 Relative Strength Index (RSI) 50.43 Average Volume (20 Days) 188,616
Income Statement In the last 12 months, Neurogene had revenue of 925K
and earned -75.14M
in profits. Earnings per share was -4.43.
Revenue 925K Gross Profit -2.32M Operating Income -82.61M Net Income -75.14M EBITDA -71.89M EBIT -75.13M Earnings Per Share (EPS) -4.43
Full Income Statement Balance Sheet The company has 136.59M in cash and 12.43M in
debt, giving a net cash position of 124.16M.
Cash & Cash Equivalents 136.59M Total Debt 12.43M Net Cash 124.16M Retained Earnings -262.3M Total Assets 315.3M Working Capital 282.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -70.6M
and capital expenditures -808K, giving a free cash flow of -71.41M.
Operating Cash Flow -70.6M Capital Expenditures -808K Free Cash Flow -71.41M FCF Per Share -4.07
Full Cash Flow Statement Margins Gross margin is -251.03%, with operating and profit margins of -8930.27% and -8123.68%.
Gross Margin -251.03% Operating Margin -8930.27% Pretax Margin -8123.68% Profit Margin -8123.68% EBITDA Margin -7771.35% EBIT Margin -8930.27% FCF Margin -7720.11%
Dividends & Yields NGNE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for NGNE is $47.5,
which is 133.3% higher than the current price. The consensus rating is "Buy".
Price Target $47.5 Price Target Difference 133.3% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 19, 2023. It was a
backward
split with a ratio of 1:4.
Last Split Date Dec 19, 2023 Split Type backward Split Ratio 1:4
Scores Altman Z-Score 6.65 Piotroski F-Score 3
